Senokot-s Tablet
NDC Package 67618-310-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Senokot-s (standardized senna concentrate and docusate sodium) tablets is a human otc drug administered via oral route. This formulation utilizes a tablet delivery system. Marketed by Atlantis Consumer Healthcare, Inc., this product is identified by NDC 67618-310 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
67618-310-60
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 60 TABLET in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
67618031060
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Senokot-s
Non-Proprietary Name
Standardized Senna Concentrate And Docusate Sodium
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.

Regulatory & Marketing

Labeler Name
Atlantis Consumer Healthcare, Inc.
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-01-1974
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67618-310). Click a package code to view its specific billing and regulatory data.

1 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
1 BOTTLE, PLASTIC in 1 CARTON / 30 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67618-310-60 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 60 tablet in 1 bottle, plastic of Senokot-s, a human over the counter drug labeled by Atlantis Consumer Healthcare, Inc.. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantis Consumer Healthcare, Inc. on October 01, 1974. The current certification is valid through December 31, 2026.

How is this Atlantis Consumer Healthcare, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67618031060. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67618-310-60
11-Digit CMS (5-4-2)
67618-0310-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.